These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 25294625)

  • 1. Clinical outcomes after continuous-flow left ventricular assist device: a systematic review.
    McIlvennan CK; Magid KH; Ambardekar AV; Thompson JS; Matlock DD; Allen LA
    Circ Heart Fail; 2014 Nov; 7(6):1003-13. PubMed ID: 25294625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced heart failure treated with continuous-flow left ventricular assist device.
    Slaughter MS; Rogers JG; Milano CA; Russell SD; Conte JV; Feldman D; Sun B; Tatooles AJ; Delgado RM; Long JW; Wozniak TC; Ghumman W; Farrar DJ; Frazier OH;
    N Engl J Med; 2009 Dec; 361(23):2241-51. PubMed ID: 19920051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.
    Sutcliffe P; Connock M; Pulikottil-Jacob R; Kandala NB; Suri G; Gurung T; Grove A; Shyangdan D; Briscoe S; Maheswaran H; Clarke A
    Health Technol Assess; 2013 Nov; 17(53):1-499, v-vi. PubMed ID: 24280231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-approval study of a highly pulsed, low-shear-rate, continuous-flow, left ventricular assist device, EVAHEART: a Japanese multicenter study using J-MACS.
    Saito S; Yamazaki K; Nishinaka T; Ichihara Y; Ono M; Kyo S; Nishimura T; Nakatani T; Toda K; Sawa Y; Tominaga R; Tanoue T; Saiki Y; Matsui Y; Takemura T; Niinami H; Matsumiya G;
    J Heart Lung Transplant; 2014 Jun; 33(6):599-608. PubMed ID: 24746637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
    Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of patients on continuous-flow left ventricular assist device support.
    Takeda K; Takayama H; Kalesan B; Uriel N; Colombo PC; Jorde UP; Naka Y
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1606-14. PubMed ID: 25260275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Third Annual Report From the ISHLT Mechanically Assisted Circulatory Support Registry: A comparison of centrifugal and axial continuous-flow left ventricular assist devices.
    Goldstein DJ; Meyns B; Xie R; Cowger J; Pettit S; Nakatani T; Netuka I; Shaw S; Yanase M; Kirklin JK
    J Heart Lung Transplant; 2019 Apr; 38(4):352-363. PubMed ID: 30945637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes After Continuous-Flow Left Ventricular Assist Device Implantation as Destination Therapy at Transplant Versus Nontransplant Centers.
    Brinkley DM; DeNofrio D; Ruthazer R; Vest AR; Kapur NK; Couper GS; Kiernan MS
    Circ Heart Fail; 2018 Mar; 11(3):e004384. PubMed ID: 29540471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Survival of Patients With Advanced Heart Failure Receiving an Left Ventricular Assist Device Intended as a Bridge to Transplantation: The Registry to Evaluate the HeartWare Left Ventricular Assist System.
    Zimpfer D; Fiane AE; Larbalestier R; Tsui S; Jansz P; Simon A; Schueler S; Strueber M; Schmitto JD
    Circ Heart Fail; 2020 Mar; 13(3):e006252. PubMed ID: 32164438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are biventricular assist devices underused as a bridge to heart transplantation in patients with a high risk of postimplant right ventricular failure?
    Bartfay SE; Dellgren G; Lidén H; Holmberg M; Gäbel J; Redfors B; Bech-Hanssen O; Karason K
    J Thorac Cardiovasc Surg; 2017 Feb; 153(2):360-367.e1. PubMed ID: 27955912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
    Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left Ventricular Assist Devices for Destination Therapy: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(3):1-60. PubMed ID: 27026798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Watchful Waiting in Continuous-Flow Left Ventricular Assist Device Patients With Ongoing Hemolysis Is Associated With an Increased Risk for Cerebrovascular Accident or Death.
    Levin AP; Saeed O; Willey JZ; Levin CJ; Fried JA; Patel SR; Sims DB; Nguyen JD; Shin JJ; Topkara VK; Colombo PC; Goldstein DJ; Naka Y; Takayama H; Uriel N; Jorde UP
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27166248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Safety and Effectiveness of the Extracorporeal Continuous-Flow Ventricular Assist Device (BR16010) Use as a Bridge-to-Decision Therapy for Severe Heart Failure or Refractory Cardiogenic Shock: Study Protocol for Single-Arm Non-randomized, Uncontrolled, and Investigator-Initiated Clinical Trial.
    Fukushima N; Tatsumi E; Seguchi O; Takewa Y; Hamasaki T; Onda K; Yamamoto H; Hayashi T; Fujita T; Kobayashi J
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):373-379. PubMed ID: 29948739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of Left Ventricular Assist Device Therapy for Advanced Heart Failure: A Review.
    Miller LW; Rogers JG
    JAMA Cardiol; 2018 Jul; 3(7):650-658. PubMed ID: 29710092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Decade of Experience With Continuous-Flow Left Ventricular Assist Devices.
    John R; Holley CT; Eckman P; Roy SS; Cogswell R; Harvey L; Shumway S; Liao K
    Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):363-375. PubMed ID: 28043445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.